MSI phenotype and MMR alterations in familial and sporadic gastric cancer

Marina Leite, Giovanni Corso, Sónia Sousa, Fernanda Milanezi, Luís P. Afonso, Rui Henrique, José Manuel Soares, Sérgio Castedo, Fátima Carneiro, Franco Roviello, Carla Oliveira, Raquel Seruca

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Microsatellite instability (MSI) is a major pathway involved in gastric carcinogenesis occurring in 20% of gastric cancer (GC). However, it is not clear whether MSI phenotype preferentially occurs in the sporadic or familial GC, when stringent inclusion criteria are used. The aim of this study was to compare the frequency of MSI and hypermethylation of MLH1 promoter in a large series of familial GC patients (non-HNPCC and non-CDH1-related) and sporadic cases. Additionally, we analysed the immunoexpression of MMR proteins in a fraction of cases. Overall, the frequency of familial GC was 7.1%, and the frequency of hereditary tumours was 4.6%. MSI phenotype and MLH1 hypermethylation frequencies were not statistical different between familial and sporadic GC settings. Further, the MSI phenotype was not associated with any clinico-pathological features studied in the familial GC setting, whereas in the sporadic setting, it was associated with older age, female gender and intestinal histotype. Using our stringent Amsterdam-based clinical criteria to select familial GC (number of cases, age of onset), we verified that sporadic and familial cases differed in gender but shared histopathological features. We verified that the frequency of MSI was similar in familial and sporadic GC settings, demonstrating that this molecular phenotype is not a hallmark of familial GC in contrast to what is verified in HNPCC. Moreover, we observed that the frequency of MLH1 hypermethylation is similar in sporadic and familial cases suggesting that in both settings MSI is not associated to MMR genetic alterations but in contrast to epigenetic deregulation.

Original languageEnglish
Pages (from-to)1606-1613
Number of pages8
JournalInternational Journal of Cancer
Volume128
Issue number7
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Microsatellite Instability
Stomach Neoplasms
Phenotype
Age of Onset
Epigenomics
Stomach
Carcinogenesis

Keywords

  • gastric cancer
  • HDGC
  • HNPCC
  • MMR
  • MSI

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Leite, M., Corso, G., Sousa, S., Milanezi, F., Afonso, L. P., Henrique, R., ... Seruca, R. (2011). MSI phenotype and MMR alterations in familial and sporadic gastric cancer. International Journal of Cancer, 128(7), 1606-1613. https://doi.org/10.1002/ijc.25495

MSI phenotype and MMR alterations in familial and sporadic gastric cancer. / Leite, Marina; Corso, Giovanni; Sousa, Sónia; Milanezi, Fernanda; Afonso, Luís P.; Henrique, Rui; Soares, José Manuel; Castedo, Sérgio; Carneiro, Fátima; Roviello, Franco; Oliveira, Carla; Seruca, Raquel.

In: International Journal of Cancer, Vol. 128, No. 7, 01.04.2011, p. 1606-1613.

Research output: Contribution to journalArticle

Leite, M, Corso, G, Sousa, S, Milanezi, F, Afonso, LP, Henrique, R, Soares, JM, Castedo, S, Carneiro, F, Roviello, F, Oliveira, C & Seruca, R 2011, 'MSI phenotype and MMR alterations in familial and sporadic gastric cancer', International Journal of Cancer, vol. 128, no. 7, pp. 1606-1613. https://doi.org/10.1002/ijc.25495
Leite, Marina ; Corso, Giovanni ; Sousa, Sónia ; Milanezi, Fernanda ; Afonso, Luís P. ; Henrique, Rui ; Soares, José Manuel ; Castedo, Sérgio ; Carneiro, Fátima ; Roviello, Franco ; Oliveira, Carla ; Seruca, Raquel. / MSI phenotype and MMR alterations in familial and sporadic gastric cancer. In: International Journal of Cancer. 2011 ; Vol. 128, No. 7. pp. 1606-1613.
@article{e67de2843535408d9b0b61fbc29a19b1,
title = "MSI phenotype and MMR alterations in familial and sporadic gastric cancer",
abstract = "Microsatellite instability (MSI) is a major pathway involved in gastric carcinogenesis occurring in 20{\%} of gastric cancer (GC). However, it is not clear whether MSI phenotype preferentially occurs in the sporadic or familial GC, when stringent inclusion criteria are used. The aim of this study was to compare the frequency of MSI and hypermethylation of MLH1 promoter in a large series of familial GC patients (non-HNPCC and non-CDH1-related) and sporadic cases. Additionally, we analysed the immunoexpression of MMR proteins in a fraction of cases. Overall, the frequency of familial GC was 7.1{\%}, and the frequency of hereditary tumours was 4.6{\%}. MSI phenotype and MLH1 hypermethylation frequencies were not statistical different between familial and sporadic GC settings. Further, the MSI phenotype was not associated with any clinico-pathological features studied in the familial GC setting, whereas in the sporadic setting, it was associated with older age, female gender and intestinal histotype. Using our stringent Amsterdam-based clinical criteria to select familial GC (number of cases, age of onset), we verified that sporadic and familial cases differed in gender but shared histopathological features. We verified that the frequency of MSI was similar in familial and sporadic GC settings, demonstrating that this molecular phenotype is not a hallmark of familial GC in contrast to what is verified in HNPCC. Moreover, we observed that the frequency of MLH1 hypermethylation is similar in sporadic and familial cases suggesting that in both settings MSI is not associated to MMR genetic alterations but in contrast to epigenetic deregulation.",
keywords = "gastric cancer, HDGC, HNPCC, MMR, MSI",
author = "Marina Leite and Giovanni Corso and S{\'o}nia Sousa and Fernanda Milanezi and Afonso, {Lu{\'i}s P.} and Rui Henrique and Soares, {Jos{\'e} Manuel} and S{\'e}rgio Castedo and F{\'a}tima Carneiro and Franco Roviello and Carla Oliveira and Raquel Seruca",
year = "2011",
month = "4",
day = "1",
doi = "10.1002/ijc.25495",
language = "English",
volume = "128",
pages = "1606--1613",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - MSI phenotype and MMR alterations in familial and sporadic gastric cancer

AU - Leite, Marina

AU - Corso, Giovanni

AU - Sousa, Sónia

AU - Milanezi, Fernanda

AU - Afonso, Luís P.

AU - Henrique, Rui

AU - Soares, José Manuel

AU - Castedo, Sérgio

AU - Carneiro, Fátima

AU - Roviello, Franco

AU - Oliveira, Carla

AU - Seruca, Raquel

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Microsatellite instability (MSI) is a major pathway involved in gastric carcinogenesis occurring in 20% of gastric cancer (GC). However, it is not clear whether MSI phenotype preferentially occurs in the sporadic or familial GC, when stringent inclusion criteria are used. The aim of this study was to compare the frequency of MSI and hypermethylation of MLH1 promoter in a large series of familial GC patients (non-HNPCC and non-CDH1-related) and sporadic cases. Additionally, we analysed the immunoexpression of MMR proteins in a fraction of cases. Overall, the frequency of familial GC was 7.1%, and the frequency of hereditary tumours was 4.6%. MSI phenotype and MLH1 hypermethylation frequencies were not statistical different between familial and sporadic GC settings. Further, the MSI phenotype was not associated with any clinico-pathological features studied in the familial GC setting, whereas in the sporadic setting, it was associated with older age, female gender and intestinal histotype. Using our stringent Amsterdam-based clinical criteria to select familial GC (number of cases, age of onset), we verified that sporadic and familial cases differed in gender but shared histopathological features. We verified that the frequency of MSI was similar in familial and sporadic GC settings, demonstrating that this molecular phenotype is not a hallmark of familial GC in contrast to what is verified in HNPCC. Moreover, we observed that the frequency of MLH1 hypermethylation is similar in sporadic and familial cases suggesting that in both settings MSI is not associated to MMR genetic alterations but in contrast to epigenetic deregulation.

AB - Microsatellite instability (MSI) is a major pathway involved in gastric carcinogenesis occurring in 20% of gastric cancer (GC). However, it is not clear whether MSI phenotype preferentially occurs in the sporadic or familial GC, when stringent inclusion criteria are used. The aim of this study was to compare the frequency of MSI and hypermethylation of MLH1 promoter in a large series of familial GC patients (non-HNPCC and non-CDH1-related) and sporadic cases. Additionally, we analysed the immunoexpression of MMR proteins in a fraction of cases. Overall, the frequency of familial GC was 7.1%, and the frequency of hereditary tumours was 4.6%. MSI phenotype and MLH1 hypermethylation frequencies were not statistical different between familial and sporadic GC settings. Further, the MSI phenotype was not associated with any clinico-pathological features studied in the familial GC setting, whereas in the sporadic setting, it was associated with older age, female gender and intestinal histotype. Using our stringent Amsterdam-based clinical criteria to select familial GC (number of cases, age of onset), we verified that sporadic and familial cases differed in gender but shared histopathological features. We verified that the frequency of MSI was similar in familial and sporadic GC settings, demonstrating that this molecular phenotype is not a hallmark of familial GC in contrast to what is verified in HNPCC. Moreover, we observed that the frequency of MLH1 hypermethylation is similar in sporadic and familial cases suggesting that in both settings MSI is not associated to MMR genetic alterations but in contrast to epigenetic deregulation.

KW - gastric cancer

KW - HDGC

KW - HNPCC

KW - MMR

KW - MSI

UR - http://www.scopus.com/inward/record.url?scp=79551478326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551478326&partnerID=8YFLogxK

U2 - 10.1002/ijc.25495

DO - 10.1002/ijc.25495

M3 - Article

C2 - 20533283

AN - SCOPUS:79551478326

VL - 128

SP - 1606

EP - 1613

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -